402 reports of this reaction
3.6% of all DEUTETRABENAZINE reports
#4 most reported adverse reaction
DEATH is the #4 most commonly reported adverse reaction for DEUTETRABENAZINE, manufactured by Teva Neuroscience, Inc.. There are 402 FDA adverse event reports linking DEUTETRABENAZINE to DEATH. This represents approximately 3.6% of all 11,218 adverse event reports for this drug.
Patients taking DEUTETRABENAZINE who experience death should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEATH is moderately reported among DEUTETRABENAZINE users, representing a notable but not dominant share of adverse events.
In addition to death, the following adverse reactions have been reported for DEUTETRABENAZINE:
The following drugs have also been linked to death in FDA adverse event reports:
DEATH has been reported as an adverse event in 402 FDA reports for DEUTETRABENAZINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEATH accounts for approximately 3.6% of all adverse event reports for DEUTETRABENAZINE, making it a notable side effect.
If you experience death while taking DEUTETRABENAZINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.